December 11, 2017
The Patented Medicine Prices Review Board (PMPRB) today published a scoping paper which provides its initial thoughts on how best to operationalize the Minister of Health’s proposed amendments to the Patented Medicines Regulations, which were published in the Canada Gazette, Part I on December 2, 2017.
October 27, 2017
The Honourable Ginette Petitpas Taylor, Federal Minister of Health, yesterday tabled the 2016 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the House of Commons and the Senate.
October 11, 2017
The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System research initiative, today published Alignment Among Public Formularies in Canada - Part 1: General Overview.
September 27, 2017
A Patented Medicine Prices Review Board (PMPRB) Hearing Panel issued its decision relating to the medicine Soliris, manufactured and marketed in Canada by Alexion Pharmaceuticals Inc.
May 24, 2017
$1 billion increase from 2014-15 fueled largely by new, higher-cost drugs